Oncotarget
Pimi induces cleavage of caspase-3 in G2/M and aneuploid cells but cell death is not blocked by pan-caspase inhibition. Cells co-treated for 48 hours with either DMSO, Pim-ci or Pimi and 20 μM of the pan-caspase inhibitor QVD-OPH were harvested and stained with propidium iodide (PI) and analyzed by FACS as well as cytospun onto glass slides, labeled with cleaved caspase-3 and analyzed by immunofluorescence. See Forshell et al.
Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution |
https://doi.org/10.18632/oncotarget.291 Justin Stebbing, Aleksandra Filipović, and Georgios Giamas |
428-429 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Is nanomedicine still promising? |
https://doi.org/10.18632/oncotarget.295 Pubudu M. Peiris, and Efstathios Karathanasis |
430-432 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Heat shock proteins and cancer therapy: The trail grows hotter! |
https://doi.org/10.18632/oncotarget.294 John R. Subjeck, and Elizabeth A. Repasky |
433-434 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Elevated PI3K signaling drives multiple Breast Cancer subtypes |
https://doi.org/10.18632/oncotarget.285 Jessica Adams, Nathan F. Schachter, Jeff C. Liu, Eldad Zacksenhaus, and Sean Eoin Egan |
435-447 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas |
https://doi.org/10.18632/oncotarget.283 Linus Plym Forshell, Yongmei Li, Tacha Zi Plym Forshell, Martina Rudelius, Lisa Nilsson, Ulrich Keller, and Jonas Nilsson |
448-460 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Strong Inhibition of Xenografted Tumor Growth by Low-Level Doses of [32P]ATP |
https://doi.org/10.18632/oncotarget.289 Yulan Cheng, Jian Yang, Rachana Agarwal, Gilbert M. Green, Ron C. Mease, Martin G. Pomper, Stephen J. Meltzer, and John M. Abraham |
461-466 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Phosphorylation of AKT: a Mutational Analysis. |
https://doi.org/10.18632/oncotarget.293 Jonathan R. Hart, and Peter K. Vogt |
467-476 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells |
https://doi.org/10.18632/oncotarget.274 Francesco Acquati, Laura Monti, Marta Lualdi, Marco Fabbri, Maria Grazia Sacco, Laura Gribaldo, and Roberto Taramelli |
477-484 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies |
https://doi.org/10.18632/oncotarget.281 Francesco Passamonti, Margherita Maffioli, Domenica Caramazza, and Mario Cazzola |
485-490 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
p21-activated kinase 1: PAK’ed with potential |
https://doi.org/10.18632/oncotarget.271 Christy Ong, Adrian Jubb, Wei Zhou, Peter Haverty, Adrian Harris, Marcia Belvin, Lori Friedman, Hartmut Koeppen, and Klaus Hoeflich |
491-496 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
RIP Kinase-Mediated Necrosis as an Alternative Mechanism of Photoreceptor Death |
https://doi.org/10.18632/oncotarget.286 Yusuke Murakami, Joan W. Miller, and Demetrios G. Vavvas |
497-509 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Targeting mTOR for the treatment of AML. New agents and new directions. |
https://doi.org/10.18632/oncotarget.290 Jessica K. Altman, Antonella Sassano, and Leonidas C. Platanias |
510-517 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
A Chemical Biology Approach to Developing STAT Inhibitors: Molecular Strategies for Accelerating Clinical Translation |
https://doi.org/10.18632/oncotarget.296 Erik A. Nelson, Sreenath V. Sharma, Jeffrey Settleman, and David A. Frank |
518-524 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC